Inspire Investing, LLC Alaunos Therapeutics, Inc. Transaction History

Inspire Investing, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$2.2 - $3.71 $220 - $371	-100 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$1.9 - $4.98 $190 - $498	100 New	100 $0
Q1 2018 Apr 13, 2018	SELL	$3.46 - $5.14 $764 - $1,135	-221 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$4.0 - $6.54 $884 - $1,445	221	221 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.